Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDKalVista Pharmaceuticals Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 6 | -$1.07 | -$0.11 | -$0.67 |
| Q2 2026 | 5 | -$0.41 | -$0.34 | -$0.37 |
| Q3 2026 | 4 | -$0.41 | -$0.11 | -$0.26 |
| Q4 2026 | 6 | -$0.79 | $0.22 | -$0.23 |
| Q1 2027 | 2 | -$0.08 | -$0.06 | -$0.07 |
| Q2 2027 | 2 | -$0.24 | -$0.16 | -$0.20 |
KalVista Pharmaceuticals Inc Earnings Date And Information
KalVista Pharmaceuticals Inc last posted its earnings results on Friday, May 15th, 2026. The company reported $-0.92 earnings per share for the quarter, missing analysts' consensus estimates of $-0.37625 by $0.54375. The company had revenue of 59.93 M for the quarter and had revenue of 73.62 M for the year. KalVista Pharmaceuticals Inc has generated $-3 earnings per share over the last year ($-3.23 diluted earnings per share) and currently has a price-to-earnings ratio of -8.36. KalVista Pharmaceuticals Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
KalVista Pharmaceuticals Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/14/2026 | Q3 2026 | N/A | -$0.11 | N/A | $33.70 M | $59.93 M |
| 12/30/2025 | Q4 2026 | N/A | -$1.08 | N/A | $5.35 M | $40.86 M |
| 11/10/2025 | Q2 2026 | -$0.96 | -$0.92 | 0.04 | $713.75 K | $13.69 M |
| 09/11/2025 | Q1 2026 | -$0.91 | -$1.12 | -0.21 | N/A | $1.43 M |
| 07/10/2025 | Q4 2025 | -$0.80 | -$1.05 | -0.25 | N/A | $0 |
| 03/12/2025 | Q3 2025 | -$0.89 | -$0.92 | -0.03 | N/A | $0 |
| 12/05/2024 | Q2 2025 | -$0.91 | -$0.91 | 0 | N/A | $0 |
| 09/05/2024 | Q1 2025 | -$0.95 | -$0.87 | 0.08 | N/A | $0 |
| 07/11/2024 | Q4 2024 | -$0.71 | -$1.02 | -0.31 | N/A | $0 |
| 03/11/2024 | Q3 2024 | -$0.75 | -$0.84 | -0.09 | N/A | $0 |
| 12/07/2023 | Q2 2024 | -$0.76 | -$0.80 | -0.04 | N/A | $0 |
| 09/07/2023 | Q1 2024 | -$0.83 | -$0.74 | 0.09 | N/A | $0 |
| 07/07/2023 | Q4 2023 | N/A | -$1.17 | N/A | N/A | $0 |
| 03/09/2023 | Q3 2023 | -$0.97 | -$0.51 | 0.46 | N/A | $0 |
| 12/08/2022 | Q2 2023 | -$1.04 | -$0.75 | 0.29 | N/A | $0 |
| 09/08/2022 | Q1 2023 | -$1.02 | -$0.94 | 0.08 | N/A | $0 |
| 07/07/2022 | Q4 2022 | -$1.06 | -$0.90 | 0.16 | N/A | $0 |
| 03/10/2022 | Q3 2022 | -$0.91 | -$0.92 | -0.01 | N/A | $0 |
| 12/09/2021 | Q2 2022 | -$0.78 | -$0.80 | -0.02 | N/A | $0 |
| 09/09/2021 | Q1 2022 | -$0.73 | -$0.66 | 0.07 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
KalVista Pharmaceuticals Inc Earnings: FAQ's
The conference call for KalVista Pharmaceuticals Inc's latest earnings report can be listened to online.
The conference call transcript for KalVista Pharmaceuticals Inc's latest earnings report can be read online.
KalVista Pharmaceuticals Inc (:KALV) has a recorded annual revenue of $73.62 M.
KalVista Pharmaceuticals Inc (:KALV) has a recorded net income of $-164,286,000.KalVista Pharmaceuticals Inc has generated $-3.23 earnings per share over the last four quarters.
KalVista Pharmaceuticals Inc (:KALV) has a price-to-earnings ratio of -8.36 and price/earnings-to-growth ratio is 0.4.